ArticleMolecular therapy : the journal of the American Society of Gene Therapy2022

An intranasal lentiviral booster reinforces the waning mRNA vaccine-induced SARS-CoV-2 immunity that it targets to lung mucosa.

Benjamin Vesin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.